- Home
- SNGX vs LSH Comparison
SNGX vs LSH Comparison
Compare SNGX & LSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- LSH
- Stock Information
- Founded
- SNGX 1987
- LSH 2018
- Country
- SNGX United States
- LSH United States
- Employees
- SNGX N/A
- LSH N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- LSH
- Sector
- SNGX Health Care
- LSH
- Exchange
- SNGX Nasdaq
- LSH NYSE
- Market Cap
- SNGX 6.5M
- LSH 6.6M
- IPO Year
- SNGX 1987
- LSH 2024
- Fundamental
- Price
- SNGX $1.28
- LSH $0.92
- Analyst Decision
- SNGX
- LSH
- Analyst Count
- SNGX 0
- LSH 0
- Target Price
- SNGX N/A
- LSH N/A
- AVG Volume (30 Days)
- SNGX 2.7M
- LSH 14.2K
- Earning Date
- SNGX 08-08-2025
- LSH 08-01-2025
- Dividend Yield
- SNGX N/A
- LSH N/A
- EPS Growth
- SNGX N/A
- LSH N/A
- EPS
- SNGX N/A
- LSH N/A
- Revenue
- SNGX $2,342.00
- LSH $16,270,095.00
- Revenue This Year
- SNGX N/A
- LSH N/A
- Revenue Next Year
- SNGX N/A
- LSH N/A
- P/E Ratio
- SNGX N/A
- LSH N/A
- Revenue Growth
- SNGX N/A
- LSH N/A
- 52 Week Low
- SNGX $1.09
- LSH $0.82
- 52 Week High
- SNGX $8.55
- LSH $4.34
- Technical
- Relative Strength Index (RSI)
- SNGX 34.55
- LSH N/A
- Support Level
- SNGX $1.09
- LSH N/A
- Resistance Level
- SNGX $1.88
- LSH N/A
- Average True Range (ATR)
- SNGX 0.14
- LSH 0.00
- MACD
- SNGX -0.01
- LSH 0.00
- Stochastic Oscillator
- SNGX 22.78
- LSH 0.00
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About LSH LAKESIDE HOLDING LTD
Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services.